Jackson Square Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,993,874
Closed -$336M 94
2018
Q1
$336M Buy
1,993,874
+504,678
+34% +$84.7M 1.68% 24
2017
Q4
$244M Sell
1,489,196
-92,205
-6% -$16.5M 1.24% 29
2017
Q3
$324M Sell
1,581,401
-171,005
-10% -$39.8M 1.57% 25
2017
Q2
$426M Sell
1,752,406
-103,595
-6% -$24.3M 2.18% 19
2017
Q1
$443M Sell
1,856,001
-1,226,061
-40% -$286M 2.18% 17
2016
Q4
$647M Sell
3,082,062
-558,843
-15% -$116M 3.35% 8
2016
Q3
$839M Sell
3,640,905
-199,255
-5% -$48.7M 3.76% 6
2016
Q2
$1B Buy
3,840,160
+205,701
+6% +$47.4M 4.22% 5
2016
Q1
$1.08B Sell
3,634,459
-58,105
-2% -$16.6M 4.31% 4
2015
Q4
$1.28B Buy
3,692,564
+425,919
+13% +$127M 4.74% 3
2015
Q3
$888M Buy
3,266,645
+490,984
+18% +$151M 4.06% 6
2015
Q2
$842M Sell
2,775,661
-29,657
-1% -$8.85M 3.22% 9
2015
Q1
$835M Buy
+2,805,318
New +$800M 3.2% 9

Other funds holding AGN

Jackson Square Partners's AGN Position: Q2 2018 in Review

Jackson Square Partners sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 1,993,874 shares — an estimated $336M sold.

Jackson Square Partners first reported a position in AGN in Q1 2015 and held it in 13 quarters. The position peaked at $1.28B in Q4 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Jackson Square Partners reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Jackson Square Partners sold 1,993,874 Allergan plc shares in Q2 2018, an estimated $336M.
  • Jackson Square Partners first reported a position in Allergan plc in Q1 2015 and held it in 13 quarters.
  • Jackson Square Partners's Allergan plc position peaked at $1.28B in Q4 2015.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Jackson Square Partners's 13F filing for Q2 2018, filed 13 Aug 2018.